Navigation Links
Orexigen® Therapeutics and Takeda Enter Into Partnership to Commercialize Contrave® in North America
Date:9/2/2010

Takeda for aspects of the development and commercialization of Contrave; the potential for the FDA to delay the scheduled PDUFA action date of January 31, 2011 due to the FDA's internal resource constraints or other reasons; the uncertainty of the FDA approval process and other regulatory requirements; the FDA may not agree with the Company's interpretation of efficacy and safety results; the FDA may require Orexigen to complete additional clinical, non-clinical or other requirements prior to the approval of the Contrave NDA; the therapeutic and commercial value of Contrave; reliance on third parties to assist with the development of Contrave and the regulatory submissions related thereto; the potential for adverse safety findings relating to Contrave; and other risks described in the Company's filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Orexigen undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. Further information regarding these and other risks is included under the heading "Risk Factors" in Orexigen's Quarterly Report on Form 10-Q, which was filed with the Securities Exchange Commission on August 6, 2010 and is available from the SEC's website (www.sec.gov) and on our website (www.orexigen.com) under the heading "Investor Relations". All forward-looking statements are qualified in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

Forward-Looking Statements Related to Takeda

This press release contains forward-looking statements regarding the Company's plans, outlook, strategies, and results for the future.  All forward-looki
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Orexigen® Therapeutics COR-BMOD Study Published in the Journal Obesity
2. Orexigen® Therapeutics Announces Publication of COR-I Phase 3 Study of Contrave in Lancet
3. Orexigen® Therapeutics Schedules August 5, 2010 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2010
4. Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity
5. Reportlinker Adds Urological Disorders Therapeutics to 2016 - Increasing Awareness and Aging Population will Drive the Benign Prostatic Hyperplasia and Urinary Incontinence Markets
6. Orexigen(R) Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
7. Echo Therapeutics Announces Successful Completion of Clinical Trial for Prelude™ SkinPrep System and 4% Lidocaine Cream
8. BioMarin Acquires ZyStor Therapeutics, Inc.
9. Nile Therapeutics Reports 2010 Second Quarter Financial Results
10. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
11. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... -- The global mHealth market ... 2020, growing at a CAGR of 47.6% from 2013 ... View Research, Inc. Monitoring services is expected to grow ... 2020.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... of chronic diseases such as cancer, heart ailments, and ...
(Date:8/27/2015)... 2015  A recent study by Feucht et ... the Arthrosurface HemiCAP® Wave implant, which is based ... design implant for isolated patellofemoral disease. While both ... pain scores, none of the patients in the ... 53% of the patients in the "onlay" group, ...
(Date:8/27/2015)... , Aug. 27, 2015 Biosimilars are ... applauds the U.S. Food and Drug Administration (FDA) ... name in its draft guidance issued today. The ... products proposes distinguishable names, calling for biological products ... FDA-designated suffix. This proposal reflects the agency,s thinking ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... 1, 2011    Advanced Biologics, ( www.advancedbiologics.com ) ... newest product within the OsteoAMP ® platform ... meeting this week in Chicago, IL.  OsteoAMP Structural ... that demonstrates osteoinductive properties in-vivo.  Initial product offerings ...
... 2011 Merz Aesthetics, Inc., the exclusive distributor of ... launch of the "STAND AND DELIVER" program.  In partnership ... selected for their significant abilities to STAND AND DELIVER, ... a stand by making a difference in their communities. ...
Cached Medicine Technology:Advanced Biologics Launches OsteoAMP® Structural at the 26th Annual Meeting of the North American Spine Society 2Merz Aesthetics and Inspirational Women Join Forces to Recognize Women Who STAND AND DELIVER 2Merz Aesthetics and Inspirational Women Join Forces to Recognize Women Who STAND AND DELIVER 3
(Date:8/30/2015)... ... August 30, 2015 , ... Lizzie’s Lice Pickers , a company that ... company is currently offering lice head checks for just $10, which is a significant ... 10% discount on their lice treatment products. “With kids returning to school, it is ...
(Date:8/30/2015)... ... August 30, 2015 , ... Scientists in France say ... a range of digestive cancers. Surviving Mesothelioma has just posted an article on the ... University of Caen measured the cancer incidence among 2,024 French asbestos plant workers from ...
(Date:8/30/2015)... ... August 30, 2015 , ... InHealth Media ( http://www.inhealthmedia.com ... Global Communications Director for InHealth Media. Mr. Spector comes with a wide ... years doing on-air television, producing shows, on air-radio and media relations. , ...
(Date:8/30/2015)... ... August 30, 2015 , ... Natural Rest contains a unique mixture ... aids and calming remedies, which help to improve mood disorders and anxiety. Like all ... of research in the field of regenerative medicine conducted by Dr. Amit Patel of ...
(Date:8/30/2015)... ... August 30, 2015 , ... Certified Nutrition Businessman Reid ... Products International and InHealth media is a global sales and communications firm that offers ... pleased to continue our business relationship with Mr. Reid Eckert, as his interpretation of ...
Breaking Medicine News(10 mins):Health News:Lizzie’s Lice Pickers Announces Back to School Head Check Special and Discounted Lice Treatment Products 2Health News:Researchers Say Mesothelioma Not the Only Cancer Linked with Asbestos Exposure, According to Surviving Mesothelioma 2Health News:InHealth Media Appoints New Global Communications Director 2Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2
... to toughen anti-smoking laws, restricting smoking in public places ... Cabinet further approved a Health and Family Welfare Ministry ... 2003 Act in the first week of the monsoon ... Dasmunsi told reporters after a Cabinet meeting in New ...
... has gripped people in Himachal Pradesh. ... Deol area of Baijnath sub-division in Himachal Pradesh's Kangra ... are suspecting the symptoms to be that of scrub ... which is spread through bites of ticks and mites. ...
... teens indulgence in non-suicidal injury is more common ... self-injury is the deliberate, direct destruction of body ... findings are important because it suggests that NSSI ... population than previously thought, says lead author Elizabeth ...
... both hands in a letter bomb explosion. Now the Austrian police ... a double hand transplant. ,His motto, he likes to ... medical wonder with an iron will, was one the victims of ... arrest in 1997 with a wave of xenophobic attacks that killed ...
... Restless legs syndrome (RLS) remains a common, yet ... years of research and increased disease recognition. ... among physicians and people with RLS, Boehringer Ingelheim ... about the symptoms, diagnosis and treatment of RLS ...
... to quality health care in India, has suggested two things ... private-public partnership. , , According to the Federation ... to spend around $203 billion (Rs 912,375 crores), if ... attained by 2012. ,The FICCI itself has put ...
Cached Medicine News:Health News:Government to Toughen Its Anti-smoking Laws 2Health News:Self-harming Among Teens More Common Than Thought 2Health News:Self-harming Among Teens More Common Than Thought 3Health News:Around the World in 86 Days ... on Motorbike With Double-hand Transplant 2Health News:Around the World in 86 Days ... on Motorbike With Double-hand Transplant 3Health News:Understanding Restless Legs Syndrome 2Health News:FICCI Proposes Models To Solve Indias Healthcare Crisis 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: